ctrl K

Price Alert

Tekla Life Sciences Inves... (HQL)

NYSE: HQL · Real-Time Price · USD

14.02

0.05 (0.36%)

At close: Aug 21, 2025, 11:24 AM

Tekla Life Sciences Investors Balance Sheet Statement

Financials in USD. Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Cash & Equivalents	n/a	477.00	445.00	990.00
Short-Term Investments	n/a	15.24M	32.94M	17.17M
Long-Term Investments	460.3M	397.53M	414.08M	534.01M
Other Long-Term Assets	13.9M	n/a	-414.08M	-534.01M
Receivables	231.11K	5.04M	623.47K	150.34K
Inventory	n/a	20.29M	33.57M	17.32M
Other Current Assets	8.97K	-20.29M	11.09M	8.46M
Total Current Assets	281.61K	5.05M	623.92K	144.66K
Property-Plant & Equipment	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	474.2M	397.53M	414.08M	534.01M
Total Assets	460.58M	402.6M	414.73M	534.19M
Account Payables	1.79K	n/a	5.1M	n/a
Deferred Revenue	n/a	n/a	5.09M	n/a
Short-Term Debt	n/a	n/a	n/a	n/a
Other Current Liabilities	886.82K	n/a	-5.1M	-9.4M
Total Current Liabilities	888.61K	n/a	5.1M	10.75M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	-1.34M
Total Long-Term Liabilities	n/a	n/a	5.1M	9.4M
Total Liabilities	888.61K	666.96K	16.82M	10.75M
Total Debt	n/a	n/a	11.09K	1.34M
Common Stock	280.61K	267.91K	256.8K	246.68K
Retained Earnings	44.13M	-1.48M	9.55M	150.7M
Comprehensive Income	n/a	n/a	-0.00	0.00
Shareholders Equity	459.69M	401.93M	397.9M	523.44M
Total Investments	460.3M	397.53M	414.08M	534.01M